Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05844865 · ClinicalTrials.gov registry record · NA
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
A NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05844865 is a NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 20 participants, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05844865, a NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Conditions Studied
Interventions
- OTHER Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples)
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center, University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05844865
The ClinicalTrials.gov registry entry for NCT05844865 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (66% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peritoneal Carcinomatosis appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) is the first listed.
NCT05844865 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05844865 about?
NCT05844865 is a clinical study titled "Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis". This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
What is the current status of trial NCT05844865?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-05-04. Estimated completion is 2026-12.
What conditions does trial NCT05844865 study?
This clinical trial studies the following conditions: Peritoneal Carcinomatosis, Gastrointestinal Peritoneal Carcinomatosis.
What interventions are being tested in trial NCT05844865?
The interventions under investigation include: Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) (OTHER).
Who is sponsoring clinical trial NCT05844865?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05844865 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peritoneal Carcinomatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
RECRUITING · Phase 2
-
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
RECRUITING · Phase 2
-
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
RECRUITING · Phase 2
Explore more on PlainTrial
Peritoneal Carcinomatosis
All registered trials for this condition
Gastrointestinal Peritoneal Carcinomatosis
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.